XML 41 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2014
Dec. 31, 2013
Assets:    
Cash $ 63,335 $ 20,096
Restricted cash 30,127 30,127
Securities available-for-sale, at estimated fair value 23,281 33,362
Securities, at estimated fair value 324,724 158,086
Interest receivable 15,183 6,022
Deferred financing costs, net 5,088 628
Other assets 975 600
Total Assets 1,554,750 907,504
Liabilities:    
Borrowings under repurchase agreements 446,224 202,033
Convertible senior notes, net 139,362 0
Participations sold 89,182 0
Derivative instrument 1,093 0
Accounts payable and accrued expenses 5,260 2,660
Payable to related party 2,966 2,628
Dividends payable 20,665 17,227
Total Liabilities 704,752 224,548
Commitments and Contingencies (see Note 15)      
Stockholders’ Equity:    
Preferred stock, $0.01 par value, 50,000,000 shares authorized, 3,450,000 shares issued and outstanding ($86,250 aggregate liquidation preference) 35 35
Common stock, $0.01 par value, 450,000,000 shares authorized, 46,848,675 and 36,888,467 shares issued and outstanding, respectively 468 369
Additional paid-in-capital 860,421 697,610
Retained earnings (accumulated deficit) (10,132) (14,188)
Accumulated other comprehensive loss (794) (870)
Total Stockholders’ Equity 849,998 682,956
Total Liabilities and Stockholders’ Equity 1,554,750 907,504
Commercial mortgage loans [Member]
    
Assets:    
Loans, held for investment 343,810 161,099
Subordinate loans [Member]
    
Assets:    
Loans, held for investment $ 748,227 $ 497,484